Zoetis Research and development expense decreased by 9.5% to $180.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $162.00M to $180.00M. Over 4 years (FY 2021 to FY 2025), Research and development expense shows an upward trend with a 8.5% CAGR.
Higher spending typically signals a commitment to long-term innovation and future product pipelines, while significant cuts may signal a shift toward short-term profitability.
This metric captures the investment in creating new products, improving existing technologies, and advancing internal ca...
Standard metric for technology and hardware firms; highly comparable to R&D spending at peers.
other_research_and_development_expense_excluding_acquire_88a3cd| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $120.00M | $132.00M | $138.00M | $122.00M | $135.00M | $134.00M | $148.00M | $142.00M | $146.00M | $152.00M | $174.00M | $162.00M | $171.00M | $167.00M | $186.00M | $162.00M | $172.00M | $170.00M | $199.00M | $180.00M |
| QoQ Change | — | +10.0% | +4.5% | -11.6% | +10.7% | -0.7% | +10.4% | -4.1% | +2.8% | +4.1% | +14.5% | -6.9% | +5.6% | -2.3% | +11.4% | -12.9% | +6.2% | -1.2% | +17.1% | -9.5% |
| YoY Change | — | — | — | — | +12.5% | +1.5% | +7.2% | +16.4% | +8.1% | +13.4% | +17.6% | +14.1% | +17.1% | +9.9% | +6.9% | +0.0% | +0.6% | +1.8% | +7.0% | +11.1% |